Cunning Capital Partners’s Elevance Health ELV Stock Holding History

Cunning Capital Partners’s Portfolio ELV Stock Details ELV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-2,880	Closed	-$1.5M	–	60
2024 Q3	$1.5M	Hold	2,880	–	–	0.78%	65
2024 Q2	$1.56M	Hold	2,880	–	–	0.87%	58
2024 Q1	$1.49M	Hold	2,880	–	–	0.83%	70
2023 Q4	$1.36M	Hold	2,880	–	–	0.85%	75
2023 Q3	$1.25M	Buy	+2,880	New	+$1.31M	0.82%	77
2023 Q2	–	Sell	-2,880	Closed	-$1.33M	–	77
2023 Q1	$1.32M	Hold	2,880	–	–	0.9%	68
2022 Q4	$1.48M	Buy	+2,880	New	+$1.46M	1.05%	52
2021 Q2	–	Sell	-15,600	Closed	-$5.6M	–	43
2021 Q1	$5.6M	Buy	+15,600	New	+$5.02M	3.49%	6

Other funds holding ELV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Cunning Capital Partners's ELV Position: Q4 2024 in Review

Cunning Capital Partners sold out of Elevance Health (ELV) in Q4 2024, closing a stake of 2,880 shares — an estimated $1.5M sold.

Cunning Capital Partners first reported a position in ELV in Q1 2021 and held it in 8 quarters. The position peaked at $5.6M in Q1 2021. 1,603 funds tracked by Wall St. Rank hold ELV as of Q4 2024.

Cunning Capital Partners reported no remaining Elevance Health position as of Q4 2024 after selling out during the quarter.
Cunning Capital Partners sold 2,880 Elevance Health shares in Q4 2024, an estimated $1.5M.
Cunning Capital Partners first reported a position in Elevance Health in Q1 2021 and held it in 8 quarters.
Cunning Capital Partners's Elevance Health position peaked at $5.6M in Q1 2021.
1,603 funds tracked by Wall St. Rank held Elevance Health as of Q4 2024.

Based on Cunning Capital Partners's 13F filing for Q4 2024, filed 13 Feb 2025.